Lannett Company, Inc. 

(Public, AMEX:LCI)   Watch this stock   
Find more results for LCI
Nov 9, 2009
Q1 2010 Earnings Conference Call
Nov 9, 2009
Q1 2010 Earnings Release
Sep 9, 2009
Q4 2009 Earnings Conference Call
Sep 9, 2009
Q4 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2009
Net profit margin 6.84% 5.53%
Operating margin 10.97% 9.06%
EBITD margin - 13.30%
Return on average assets 8.10% 5.52%
Return on average equity 12.73% 8.90%
Employees 277 -

Address

9000 State Road
Philadelphia, PA 19136
United States - Map
+1-215-3339000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Lannett Company, Inc. discussed on blogs

BioMedReports.com - webmaster - BioMedReports.Com - Jun 14, 2009

Lannett Company, Inc. discussions

  View all discussions »

Description

Lannett Company, Inc. (Lannett) develops, manufactures, markets and distributes generic versions of pharmaceutical products. The Company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations. As of June 30, 2009, the Company had two facilities in Philadelphia, Pennsylvania. Its wholly owned subsidiaries include Lannett Holdings, Inc. and Cody Laboratories, Inc.

Officers and directors

William R. Farber Ph.D.
Chairman of the Board
Age: 78
Bio & Compensation - Reuters
Arthur P. Bedrosian J.D.
President, Chief Executive Officer, Director
Age: 63
Bio & Compensation - Reuters
Ronald A. West
Vice Chairman of the Board
Age: 75
Bio & Compensation - Reuters
Keith R. Ruck CPA
Chief Financial Officer, Vice President, Controller
Age: 48
Bio & Compensation - Reuters
William Schreck
Senior Vice President, General Manager
Age: 60
Bio & Compensation - Reuters
Stephen J. Kovary
Vice President - Operations
Age: 52
Bio & Compensation - Reuters
Ernest Sabo
Vice President - Regulatory Affairs, Chief Compliance Officer
Age: 61
Bio & Compensation - Reuters
Kevin Smith
Vice President - Sales and Marketing
Age: 49
Bio & Compensation - Reuters
Myron Winkelman
Director
Age: 71
Bio & Compensation - Reuters
Albert I. Wertheimer Ph.D.
Director
Age: 67
Bio & Compensation - Reuters